Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): A partial-factorial randomised controlled trial

The Lancet

Volumn 385, Issue 9968, 2015, Pages 617-628

  Bath, Philip M W ^a   Woodhouse, Lisa ^b   Scutt, Polly ^b   Krishnan, Kailash ^b   Wardlaw, Joanna M ^b   Bereczki, Daniel ^b   Sprigg, Nikola ^b   Berge, Eivind ^b   Beridze, Maia ^b   Caso, Valeria ^b   Chen, Christopher ^b   Christensen, Hanne ^b   Collins, Ronan ^b   El Etribi, Anwar ^b   Laska, Ann Charlotte ^b   Lees, Kennedy R ^b   Ozturk, Serefnur ^b   Phillips, Steve ^b   Pocock, Stuart ^b   De Silva, H Asita ^b   Szatmari, Szabolcs ^b   Utton, Sally ^b   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLYCERYL TRINITRATE; VASODILATOR AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; COMPLICATION; CONVALESCENCE; DISEASE MANAGEMENT; MIDDLE AGED; ODDS RATIO; SINGLE BLIND PROCEDURE; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITROGLYCERIN; ODDS RATIO; RECOVERY OF FUNCTION; SINGLE-BLIND METHOD; STROKE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84923035699     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61121-1     Document Type: Article

References (47)

1. J Leonardi-Bee, PMW Bath, SJ Phillips, PAG Sandercock for the IST Collaborative Group Blood pressure and clinical outcomes in the International Stroke Trial Stroke 33 2002 1315 1320
2. M Willmot, J Leonardi-Bee, PM Bath High blood pressure in acute stroke and subsequent outcome: a systematic review Hypertension 43 2004 18 24
3. N Sprigg, LJ Gray, PM Bath et al. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial J Hypertens 24 2006 1413 1417
4. C Geeganage, M Tracy, T England et al. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) Stroke 42 2011 491 493
5. EC Sandset, PM Bath, G Boysen et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial Lancet 377 2011 741 750
6. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial Lancet 363 2004 439 445
7. J He, Y Zhang, T Xu et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS Randomized Clinical Trial JAMA 311 2014 479 489
8. CS Anderson, E Heeley, Y Huang et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage N Engl J Med 368 2013 2355 2365
9. C Geeganage, PMW Bath Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression Hypertension 54 2009 775 781
10. MR Willmot, PMW Bath The potential of nitric oxide therapeutics in stroke Expert Opin Investig Drugs 12 2003 455 470
11. M Willmot, S Murphy, J Leonardi-Bee, P Bath Systematic review of nitric oxide donors and L-arginine in experimental stroke: effects on infarct size and cerebral blood flow Nitric Oxide 12 2005 141 149
12. RJ Butterworth, A Cluckie, SH Jackson, M Buxton-Thomas, PM Bath Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke Cerebrovasc Dis 8 1998 158 165
13. PMW Bath, R Pathansali, R Iddenden, FJ Bath The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke Cerebrovasc Dis 11 2001 265 272
14. P Rashid, C Weaver, J Leonardi-Bee, F Bath, S Fletcher, P Bath The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke J Stroke Cerebrovasc Dis 12 2003 143 151
15. M Willmot, A Ghadami, B Whysall, W Clarke, J Wardlaw, PM Bath Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke Hypertension 47 2006 1209 1215
16. S Ankolekar, M Fuller, I Cross et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) Stroke 44 2013 3120 3128
17. B Neal, S MacMahon, N Chapman for the Blood Pressure Lowering Treatment Trialists' Collaboration Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials Lancet 356 2000 1955 1964
18. P Rashid, J Leonardi-Bee, P Bath Blood pressure reduction and the secondary prevention of stroke and other vascular events: a systematic review Stroke 34 2003 2741 2749
19. KR Lees, AG Dyker Blood pressure control after acute stroke J Hypertens 14 1996 S35 S38
20. PMW Bath, C Weaver, R Iddenden, FJ Bath A trial of blood pressure reduction in acute stroke Age Ageing 29 2000 554 555
21. TG Robinson, JF Potter, GA Ford for the COSSACS Investigators Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial Lancet Neurol 9 2010 767 775
22. EC Sandset, PM Bath, G Boysen for the SCAST Study Group The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled double-blind trial Lancet 377 2011 741 750
23. DH Barer, JM Cruickshank, SB Ebrahim, JR Mitchell Low dose beta blockade in acute stroke ("BEST" trial): an evaluation BMJ 296 1988 737 741
24. NG Wahlgren, DG MacMahon, J de Keyser, B Indredavik, T Ryman for the INWEST Study Group Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke Cerebrovasc Dis 4 1994 204 210
25. GM Fischberg, E Lozano, K Rajamani, S Ameriso, MJ Fisher Stroke precipitated by moderate blood pressure reduction J Emerg Med 19 2000 339 346
26. The ENOS Trial Investigators Glyceryl trinitrate vs control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122) Int J Stroke 1 2006 245 249
27. PM Bath, A Houlton, L Woodhouse, N Sprigg, J Wardlaw, S Pocock for the ENOS Trialists Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial Int J Stroke 9 2014 372 374
28. J Bamford, P Sandercock, M Dennis, J Burn, C Warlow Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1991 1521 1526
29. E Lindenstrom, G Boysen, LW Christiansen, B Rogvi Hansen, PW Nielsen Reliability of scandinavian neurological stroke scale Cerebrovascular Diseases 1 1991 103 107
30. KR Lees, PMW Bath, PD Schellinger et al. Contemporary outcome measures in acute stroke research: choice of primary outcome measure Stroke 43 2012 1163 1170
31. G Sulter, C Steen, J de Keyser Use of the Barthel Index and modified Rankin Scale in acute stroke trials Stroke 30 1999 1538 1541
32. T Metitieri, C Geroldi, A Pezzini, GB Frisoni, A Bianchetti, M Trabucchi The ITLE-MMSE: an Italian telephone version of the mini-mental state examination Int J Geriatr Psychiatry 16 2001 166 167
33. DW Desmond, TK Tatemichi, L Hanzawa The telephone interview for cognitive status (TICS): reliability and validity in a stroke sample Int J Geriatr Psychiatry 9 1994 803 807
34. DK Whynes, N Sprigg, J Selby, E Berge, PM Bath Testing for differential item functioning within the EQ-5D Med Decis Making 33 2013 252 260
35. WWK Zung A self-rating depression scale Arch Gen Psychiatry 12 1965 63 70
36. PD Schellinger, PMW Bath, K Lees et al. Assessment of addtional endpoints relevant to the benefit of patients after stroke - what, when, where, in whom Int J Stroke 7 2012 227 230
37. PMW Bath, E Lindenstrom, G Boysen et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial Lancet 358 2001 702 710
38. PM Bath, LJ Gray, T Collier, S Pocock, J Carpenter for the Optimising Analysis of Stroke Trials (OAST) Collaboration Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials Stroke 38 2007 1911 1915
39. PM Bath, KR Lees, PD Schellinger et al. Statistical analysis of the primary outcome in acute stroke trials Stroke 43 2012 1171 1178
40. CJ Weir, KR Lees Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial Stat Med 22 2003 705 726
41. S Ankolekar, C Renton, G Sare, S Ellender, N Sprigg, JM Wardlaw, PM Bath ENOS Trial Investigators Relationship between poststroke cognition, baseline factors, and functional outcome: data from "efficacy of nitric oxide in stroke" trial J Stroke Cerebrovasc Dis 23 2014 1821 1829
42. LJ Gray, M Ali, PD Lyden, PM Bath Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke J Stroke Cerebrovasc Dis 18 2009 466 468
43. C Geeganage, PM Bath Interventions for deliberately altering blood pressure in acute stroke Cochrane Database Syst Rev 4 2008 CD000039.
44. M Jusufovic, EC Sandset, PM Bath, E Berge for the Scandinavian Candesartan Acute Stroke Trial Study Group Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke Stroke 2014 published online Sept 25. http://dx.doi.org/10.1161/STROKEAHA.114.006433
45. PM Bath, R Pathansali, R Iddenden, FJ Bath The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke Cerebrovasc Dis 11 2001 265 272
46. J Dachtler, NR Hardingham, K Fox The role of nitric oxide synthase in cortical plasticity is sex specific J Neurosci 32 2012 14994 14999
47. P Rashid, C Weaver, JA Leonardi-Bee, S Fletcher, FJ Bath, PMW Bath The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke J Stroke Cerebrovasc Dis 13 2003 143 151